Zusammenfassung
Vaginalkarzinome gehören zu den seltenen Tumoren (etwa 500 Fälle pro Jahr in Deutschland). Risikofaktoren sind die HPV-Infektion, Immundepression, Nikotinabusus und HPV-assoziierte Vorerkrankungen der Cervix uteri und der Vulva. Als teilweise Primärprävention kann die HPV-Impfung gelten. Eine systematische Früherkennung existiert angesichts der Seltenheit der Erkrankung nicht. Auffällige zytologische Befunde bei fehlender oder unauffälliger Zervix sollten zu einer intensivierten Untersuchung mit Inspektion und Kolposkopie veranlassen. Es handelt sich überwiegend um Plattenepithelkarzinome. Die definitive Diagnostik erfolgt durch histologische Sicherung. Zum Staging werden erst in fortgeschritteneren Stadien bildgebende Verfahren eingesetzt. Im Stadium I kann eine operative Resektion durchgeführt werden, die übrigen Stadien werden einer Radio(chemo)therapie zugeführt. Als Lymphabflussgebiete der Vaginalkarzinome müssen sowohl inguinofemoralen als auch die pelvinen Lymphknoten gelten. Das Sentinel-Verfahren kann zur Beschränkung der Therapieausdehnung eingesetzt werden.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Zaspel U, Hamm W (2007) Vagina. In: Hamm B, Forstner R (Hrsg) MRT and CT of the female pelvis. Springer Heidelberg, S 275–292
Literatur zu Abschn. 9.1
Daling JR, Madeleine MM, Schwartz SM et al (2002) A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 84:263–270
Madsen BS et al (2008) Risk factors for invasive squamous cell carcinoma of the vulva and vagina – population-based case-control study in Denmark. Int J Cancer 122:2827
Robboy SJ et al (1984) Atypical vaginal adenosis and cervical ectropion. Association with clear cell adenocarcinoma in diethylstilbestrol-exposed offspring. Cancer 54(5):869
Shah CA et al (2009) Factors affecting risk of mortality in women with vaginal cancer. Obstet Gynecol 113:1038–1045
Siegel RL, Miller KD, Jemal A (2017) Cancer statistics. CA Cancer J Clin 67:7
Strander B et al (2007) Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study. BMJ 335:1077
Literatur zu Abschn. 9.2
Alemany L, Saunier M, Tinoco L et al (2014) Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples. Eur J Cancer 50:2846–2854
Daling JR, Madeleine MM, Schwartz SM et al (2002) A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 84:263–270
Garland SM, Hernandez-Avila M, Wheeler CM et al (2007) Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Eng J Med 356:1928–1943
Joura EA, Leodolter S, Hernandez-Avila M et al (2007) Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet 369:1693–1702
Joura EA, Garland SM, Paavonen J et al (2012) Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data. BMJ 344:e1401
Karam A, Berek JS, Kidd EA, Falk SJ (2017) Vaginal cancer. UpToDate https://www.uptodate.com/contents/vaginal-cancer
Kjaer SK, Sigurdsson K, Iversen OE et al (2009) A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Cancer Prev Res 2:868–878
Olsson SE, Kjaer SK, Sigurdsson K et al (2009) Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection. Human Vaccines 5:696–704
Sherman JF, Mount SL, Evans MF, Skelly J, Simmons-Arnold L, Eltabbakh GH (2008) Smoking increases the risk of high-grade vaginal intraepithelial neoplasia in women with oncogenic human papillomavirus. Gynecol Oncol 110:396–401
Sinno AK, Saraiya M, Thompson TD et al (2014) Human papillomavirus genotype prevalence in invasive vaginal cancer from a registry-based population. Obstet Gynecol 123:817–821
Literatur zu Abschn. 9.3
Aktas M, de Jong D, Nuyttens JJ, van der Zee J, Wielheesen DH, Batman E, Burger CW, Ansink AC (2007) Concomitant radiotherapy and hyperthermia for primary carcinoma of the vagina: a cohort study. Eur J Obstet Gynecol Reprod Biol 133(1):100–104
Alemany L, Saunier M, Tinoco L, Quirós B, Alvarado-Cabrero I, Alejo M, Joura EA, Maldonado P, Klaustermeier J, Salmerón J, Bergeron C, Petry KU, Guimerà N, Clavero O, Murillo R, Clavel C, Wain V, Geraets DT, Jach R, Cross P, Carrilho C, Molina C, Shin HR, Mandys V, Nowakowski AM, Vidal A, Lombardi L, Kitchener H, Sica AR, Magaña-León C, Pawlita M, Quint W, Bravo IG, Muñoz N, de Sanjosé S, Bosch FX, VVAP study group HPV (2014) Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples. Eur J Cancer 50(16):2846–2854
Atienza-Amores M, Guerini-Rocco E, Soslow RA, Park KJ, Weigelt B (2014) Small cell carcinoma of the gynecologic tract: a multifaceted spectrum of lesions. Gynecol Oncol 134(2):410–418
Bing Z, Levine L, Lucci JA, Hatch SS, Eltorky MA (2004) Primary small cell neuroendocrine carcinoma of the vagina: a clinicopathologic study. Arch Pathol Lab Med 128(8):857–862
Chamié LP, Ribeiro DMFR, Tiferes DA, Macedo Neto AC, Serafini PC (2018) atypical sites of deeply infiltrative endometriosis: clinical characteristics and imaging findings. Radiographics 38(1):309–328
Corless CL (2014) Gastrointestinal stromal tumors: what do we know now? Mod Pathol 27(Suppl 1):S 1–16
Curtin JP, Saigo P, Slucher B, Venkatraman ES, Mychalczak B, Hoskins WJ (1995) Soft-tissue sarcoma of the vagina and vulva: a clinicopathologic study. Obstet Gynecol 86(2):269–272
de Sanjosé S, Bruni L, Alemany L (2014) HPV in genital cancers (at the exception of cervical cancer) and anal cancers. Presse Med 43(12 Pt 2):e423–428
Del Pino M, Rodriguez-Carunchio L, Ordi J (2013) Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma. Histopathology 62(1):161–175
Deng Z, Hasegawa M, Aoki K, Matayoshi S, Kiyuna A, Yamashita Y, Uehara T, Agena S, Maeda H, Xie M, Suzuki M (2014) A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma. Int J Oncol 45(1):67–76
Ferenczy AS, Colgan TJ, Herrington CS, Hisrchowitz L, Löning T, Park KJ, Stoler M, Wells M, Wilbur DC, Wright T (2014) Epithelial tumors of the vagina. In: Kurman RJ, Carcangiou ML, Herrington S, Young RH (Hrsg) WHO classification of tumours of femal reproductive organs. IARC Press, Lyon, S 210–217
Ferreira M, Crespo M, Martins L, Félix A (2008) HPV DNA detection and genotyping in 21 cases of primary invasive squamous cell carcinoma of the vagina. Mod Pathol 21(8):968–972
Frank SJ, Jhingran A, Levenback C, Eifel PJ (2005) Definitive radiation therapy for squamous cell carcinoma of the vagina. Int J Radiat Oncol Biol Phys 1 62 (1):138–147
Fuste V, del Pino M, Perez A, Garcia A, Torne A, Pahisa J, Ordi J (2010) Primary squamous cell carcinoma of the vagina: human papillomavirus detection, p16 (INK4A) overexpression and clinicopathological correlations. Histopathology 57(6):907–916
Gadducci A, Fabrini MG, Lanfredini N, Sergiampietri C (2015) Squamous cell carcinoma of the vagina: natural history, treatment modalities and prognostic factors. Crit Rev Oncol Hematol 93(3):211–224
Ghezelayagh T, Rauh-Hain JA, Growdon WB (2015) Comparing mortality of vaginal sarcoma, squamous cell carcinoma, and adenocarcinoma in the surveillance, epidemiology, and end results database. Obstet Gynecol 125(6):1353–1361
Goodman A, Schorge J, Greene MF (2011) The long-term effects of in utero exposures – the DES story. N Engl J Med 2 364 (22): 2083–2084
Gunderson CC, Nugent EK, Yunker AC, Rocconi RP, Graybill WS, Erickson BK, Moore KN (2013) Vaginal cancer: the experience from 2 large academic centers during a 15-year period. J Low Genit Tract Dis 17(4):409–413
Hellman K, Johansson H, Andersson S, Pettersson F, Auer G (2013) Prognostic significance of cell cycle- and invasion-related molecular markers and genomic instability in primary carcinoma of the vagina. Int J Gynecol Cancer 23(1):41–51
Hellman K, Lindquist D, Ranhem C, Wilander E, Andersson S (2014) Human papillomavirus, p16 (INK4A), and Ki-67 in relation to clinicopathological variables and survival in primary carcinoma of the vagina. Br J Cancer 18 110(6): 1561–1570
Hiniker SM, Roux A, Murphy JD, Harris JP, Tran PT, Kapp DS, Kidd EA (2013) Primary squamous cell carcinoma of the vagina: prognostic factors, treatment patterns, and outcomes. Gynecol Oncol 131(2):380–385
Höckel M, Horn LC, Illig R, Dornhöfer N, Fritsch H (2011) Ontogenetic anatomy of the distal vagina: relevance for local tumor spread and implications for cancer surgery. Gynecol Oncol 122(2):313–318
Horn LC, Fischer U, Reuter S, Pyttel C (1998) Leiomyosarcoma and leiomyoma of the vagina. Zentralbl Gynakol 120(1):38–41
Horn LC, Brambs CE, Opitz S, et al (2018) TNM 2017 und WHO 2014 – Problematisches und Unklares bei gynäkologischen Tumoren. Pathologe [submitted for publication]
Joensuu H, Hohenberger P, Corless CL (2013) Gastrointestinal stromal tumour. Lancet 14 382 (9896): 973–983
Khosla D, Patel FD, Kumar R, Gowda KK, Nijhawan R, Sharma SC (2014) Leiomyosarcoma of the vagina: a rare entity with comprehensive review of the literature. Int J Appl Basic Med Res 4(2):128–130
Khurana A, Gupta G, Gupta M, Kaur M (2013) Primary neuroendocrine carcinoma of the vagina with coexistent atypical vaginal adenosis: a rare entity. J Cancer Res Ther 9(2):328–330
Lam MM, Corless CL, Goldblum JR, Heinrich MC, Downs-Kelly E, Rubin BP (2006) Extragastrointestinal stromal tumors presenting as vulvovaginal/rectovaginal septal masses: a diagnostic pitfall. Int J Gynecol Pathol 25(3):288–292
Leitlinie Vaginalkarzinom (2018) Vaginalkarzinom: Diagnostik, Therapie und Nachsorge. S2k-Leitlinie der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG). AWMF-Registernummer 032/042
Lilic V, Lilic G, Filipovic S, Visnjic M, Zivadinovic R (2010) Primary carcinoma of the vagina. J BUON 15(2):241–247
Medeiros LR, Rosa MI, Silva BR, Reis ME, Simon CS, Dondossola ER, da Cunha Filho JS (2015) Accuracy of magnetic resonance in deeply infiltrating endometriosis: a systematic review and meta-analysis. Arch Gynecol Obstet 291(3):611–621
McCluggage G (2013) Vulvovaginal Mesenchymal Lesions. In: Brown B (Hrsg) Pathology of the vulva and vagina. Springer, Heidelberg, S 207–244
Miettinen M, Fletcher CDM, Kindblom LG, Tsui WMS (2010) Mesenchymal tumors oft he stomach. In: Bosman FT, Cerbeiro F, Hruban RH, Theisse ND (Hrsg) WHO classification of tumours oft he digestive system. IARC Press, Lyon, S 74–79
Nagase S, Mikami Y, Moriya T, Niikura H, Yoshinaga K, Takano T, Ito K, Akahira J, Sasano H, Yaegashi N (2007) Vaginal tumors with histologic and immunocytochemical feature of gastrointestinal stromal tumor: two cases and review of the literature. Int J Gynecol Cancer 17(4):928–933
Naves AE, Monti JA, Chichoni E (1980) Basal cell-like carcinoma in the upper third of the vagina. Am J Obstet Gynecol 137(1):136–137
Ngan HY, Fisher C, Blake P, Shepherd JH (1994) Vaginal sarcoma: the Royal Marsden experience. Int J Gynecol Cancer 4(5):337–341
Nomura H, Matoda M, Okamoto S, Omatsu K, Kondo E, Kato K, Umayahara K, Takeshima N (2015) Clinical characteristics of non-squamous cell carcinoma of the vagina. Int J Gynecol Cancer 25(2):320–324
Nucci MR, Fletcher CD (2000) Vulvovaginal soft tissue tumours: update and review. Histopathology 36(2):97–108
Nucci MR, Ganesan R, McCluggage WG, Nielsen GP (2014) Soft tissue tumors of the vulva. In: Kurman RJ, Carcangiou ML, Herrington S, Young RH (Hrsg) WHO classification of tumours of femal reproductive organs. IARC Press, Lyon, S 243–249
Oliveira R, Bócoli MC, Saldanha JC, Murta EF, Nomelini RS (2013) Primary small cell carcinoma of the vagina. Case Rep Obstet Gynecol 2013:827037
Rajaram S, Maheshwari A, Srivastava A (2015) Staging for vaginal cancer. Best Pract Res Clin Obstet Gynaecol 29(6):822–832
Sayeed S, Xing D, Jenkins SM, Weisman PS, Buehler D, Warmke L, Uram-Tuculescu C, Bakkum-Gamez JN, Howitt BE, Cortese C, Park KJ, Schoolmeester JK (2018) Criteria for risk stratification of vulvar and vaginal smooth muscle tumors: an evaluation of 71 cases comparing proposed classification systems. Am J Surg Pathol 42(1):84–94
Schrager S, Potter BE (2004) Diethylstilbestrol exposure. Am Fam Physician 15 69(10): 2395–2400
Seifried S, Haydu LE, Quinn MJ, Scolyer RA, Stretch JR, Thompson JF (2015) Melanoma of the vulva and vagina: principles of staging and their relevance to management based on a clinicopathologic analysis of 85 cases. Ann Surg Oncol 22(6):1959–1966
Smith EK, White MC, Weir HK, Peipins LA, Thompson TD (2012) Higher incidence of clear cell adenocarcinoma of the cervix and vagina among women born between 1947 and 1971 in the United States. Cancer Causes Control 23(1):207–211
Staats PN, Clement PB, Young RH (2007) Primary endometrioid adenocarcinoma of the vagina: a clinicopathologic study of 18 cases. Am J Surg Pathol 31(10):1490–1501
Staats PN, McCluggage WG, Clement PB, Young RH (2014) Primary intestinal-type glandular lesions of the vagina: clinical, pathologic, and immunohistochemical features of 14 cases ranging from benign polyp to adenoma to adenocarcinoma. Am J Surg Pathol 38(5):593–603
Yan WX, Jia XJ, Chen YB, Zhao ZX, Liu XL, Yang JZ, Wang TJ (2016) Primary small cell carcinoma of the vagina with pulmonary metastasis: a case report. Eur J Gynaecol Oncol 37(1):129–132
Zhang W, Peng Z, Xu L (2009) Extragastrointestinal stromal tumor arising in the rectovaginal septum: report of an unusual case with literature review. Gynecol Oncol 113(3):399–401
Literatur zu Abschn. 9.4
Al-Kurdi M, Monaghan JM (1981) Thirty-two years experience in management of primary tumours of the vagina. Br J Obstet Gynaecol 88:1145–1150
Alt CD et al (2011) Imaging of Female Pelvic Malignancies with MRI CT, and PET/CT (part 2). Strahlenther Onkol 187:705–714
Alt CD (2015) Weibliches Becken. In: Krombach GA, et al (Hrsg) Radiologische Diagnostik Abdomen und Thorax. Thieme, Stuttgart, S 648–687. https://doi.org/10.1055/b-0035-109228
Baltzer J et al (2005) Klassifikation maligner Tumoren der weiblichen Genitalorgane. Springer, Heidelberg
Bidus MA, Elkas JC (2007) Cervical and vaginal cancer. In: Berek JS (Hrsg) Berek and Novak’s gynecology, 14. Aufl. Lippincott Williams and Wilkins, Philadelphia, S 1403–1456
Bipat S et al (2003) Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. Gynecol Oncol 91:59–66
Brown MA et al (2005) MRI of the female pelvis using vaginal gel. Am J Roentgenol 185:1221–1227
Chang YC et al (1988) Vagina: evaluation with MR imaging. Part II. Neoplasms. Radiology 169:175–179. https://doi.org/10.1148/radiology.169.1.3420257
Charles-Edwards EM et al (2008) Diffusion-weighted imaging in cervical cancer with an endovaginal technique: potential value for improving tumor detection in stage Ia and Ib1 disease. Radiology 249:541–550
Choi HJ et al (2010) Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with cervical cancer: metaanalysis. Cancer Science 101:1471–1479
Costa S (2013) Vagina. In: Kaufmann M, Costa S, Scharl A (Hrsg) Die Gynäkologie. Springer, Heidelberg, S 429–436
Eifel PJ et al (2005) Cancer of the cervix, vagina, and vulva. In: DeVita VT, Hellman S, Rosenberg SA (Hrsg) Cancer principles and practice. Lippincott Williams & Wilkins, Philadelphia, S 1295–1341
Elsayes KM et al (2007) Vaginal masses: magnetic resonance imaging features with pathologic correlation. Acta Radiol 48:921–933
Ferenczy AS et al (2014) Tumors of the vagina. In: Kurman J, Carcanglu ML, Herrington CS, Young RH (Hrsg) WHO classification of tumours of female reproductive organs. IARC Press, Lyon
Freeman S et al (2012) The revised FIGO staging system for uterine malignancies: implications for MR imaging. RadioGraphics 32:1805–1827
Gardner CS et al (2015) Primary vaginal cancer: role of MRI in diagnosis, staging and treatment. Br J Radiol 88:20150033
Gong Y, et al (2016) Different imaging techniques for the detection of pelvic lymph nodes metastasis from gynecological malignancies: a systematic review and meta-analysis. Oncotarget [epub ahead of print]. https://doi.org/10.18632/oncotarget.12959
Gouy S et al (2013) Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of positron emission tomography imaging. J Clin Oncol 31(24):3026–3033
Griffin N et al (2008) Magnetic resonance imaging of vaginal and vulval pathology. Eur Radiol 18:1269–1280
Hallscheidt P, Haferkamp A (2010) Urogenitale Bildgebung. Springer, Heidelberg
Husain A et al (2007) A prospective study of the accuracy of 18fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration. Gynecol Oncol 106:177–180
Kang S et al (2010) Diagnostic value of 18F-FDG PET for evaluation of paraaortic nodal metastasis in patients with cervical carcinoma: a meta-analysis (Structured abstract). J Nuc Med 51:360–367
Kinkel K et al (1997) Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast enhanced subtraction MR imaging. Radiology 204:55–63
Lamoreaux WT et al (2005) FDG-PET evaluation of vaginal carcinoma. Int J Radiat Oncol Biol Phys 62:733–737
Lee LJ et al (2013) ACR appropriateness criteria management of vaginal cancer. Oncology (Williston Park) 27:1166–1173
Leitlinie Kolorektales Karzinom (2014) Kolorektales Karzinom. S3-Leitlinie des Leitlinienprogramms Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF), Langversion. AWMF-Registernummer: 021-007OL
Leitlinie Mammakarzinom (2012) Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms, Langversion 3.0. Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF). AWMF-Registernummer: 032–0450L
Leitlinie Vaginalkarzinom (2018) Vaginalkarzinom: Diagnostik, Therapie und Nachsorge. S2k-Leitlinie der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG). AWMF-Registernummer 032/042
Leitlinie Zervixkarzinom (2014) Diagnostik, Therapie und Nachsorge der Patientin mit Zervixkarzinom, Langversion. S3-Leitlinie des Leitlinienprogramms Onkologie (AWMF, Deutsche Krebsgesellschaft, Deutsche Krebshilfe). AWMF-Registernummer: 032/033OL
Malayeri AA et al (2011) Principles and applications of diffusionweighted imaging in cancer detection, staging, and treatment follow-up. Radiographics 31:1773–1791
Parikh J et al (2008) MR imaging features of vaginal malignancies. RadioGraphics 28:49–63
Peters WA et al (1985) Microinvasive carcinoma of the vagina: a distinct clinical entity? Am J Obstet Gynecol 153:505–507
Pfleiderer A, Kaufmann M (2011) Anatomie, Topographie und Funktion der weiblichen Genitalorgane. In: Breckwoldt M, Kaufmann M, Pfleiderer A (Hrsg) Gynäkologie und Geburtshilfe. Thieme, Stuttgart, S 14–25
Plentl AA, Friedman EA (1971) Lymphatic system of the female genitalia. The morphologic basis of oncologic diagnosis and therapy. Major Probl Obstet Gynecol 2:1–223
James RM, Cruickshank ME, Siddiqui N; Guideline Development Group (2008) Management of cervical cancer: summary of SIGN guidelines. BMJ 336(7634):41–43
Taylor MB et al (2007) Magnetic resonance imaging of primary vaginal carcinoma. Clin Radiol 62:549–555. https://doi.org/10.1016/j.crad.2007.01.008
Thomeer MG et al (2013) Clinical examination versus magnetic resonance imaging in the pretreatment staging of cervical carcinoma: systematic review and meta-analysis. Eur Radiol 23:2005–2018
Tsai CS et al (2010) A prospective randomized trial to study the impact of pretreatment FDG-PET for cervical cancer patients with MRI-detected positive pelvic but negative para-aortic lymphadenopathy. Int J Radiat Oncol Biol Phys 76:477–484
Waggoner SE et al (1994) Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma. Gynecol Oncol 55:238–244
Walker D et al (2011) Overlooked diseases of the vagina: a directed anatomic-pathologic approach for imaging assessment. RadioGraphics 31:1583–1598
Wittekind C (2017) TNM Klassifikation maligner Tumoren, 8. Aufl. Wiley-Blackwell, Weinheim
Literatur zu Abschn. 9.5
Choi YJ, Hur SY, Park JS, Lee KH (2013) Laparoscopic upper vaginectomy for post-hysterectomy high risk vaginal intraepithelial neoplasia and superficially invasive vaginal carcinoma. World J Surg Oncol 3 (11): 126. https://doi.org/10.1186/1477-7819-11-126. PMID: 23725440)
Gadducci A, Fabrini MG, Lanfredini N, Sergiampietri C (2015) Squamous cell carcinoma of the vagina: natural history, treatment modalities and prognostic factors. Crit Rev Oncol Hematol 93(3):211–224
Höckel M, Horn LC, Einenkel J (2012) (Laterally) extended endopelvic resection: surgical treatment of locally advanced and recurrent cancer of the uterine cervix and vagina based on ontogenetic anatomy. Gynecol Oncol 127(2):297–302
Houghton CR, Iversen T (1982) Squamous cell carcinoma of the vagina: a clinical study of the location of the tumor. Gynecol Oncol 13(3):365–372
Jain V, Sekhon R, Giri S, Bora RR, Batra K, Bajracharya A, Rawal S (2016) Role of radical surgery in early stages of vaginal cancer. Our experience. Int J Gynecol Cancer 26(6):1176–1181
Li Y, Chen Y, Xu H, Wang D, Wang Y, Liang Z (2012) Laparoscopic nerve-sparing radical vaginectomy in patients with vaginal carcinoma: surgical technique and operative outcomes. J Minim Invasive Gynecol 19(5):593–597
Ling B, Gao Z, Sun M, Sun F, Zhang A, Zhao W, Hu W (2008) Laparoscopic radical hysterectomy with vaginectomy and reconstruction of vagina in patients with stage I of primary vaginal carcinoma. Gynecol Oncol 109(1):92–96. https://doi.org/10.1016/j.ygyno.2007.12.012
Luo LM, Huang HF, Pan LY, Shen K, Wu M, Xu L (2008) Clinical analysis of 42 cases of primary malignant tumor in vagina. Zhonghua Fu Chan Ke Za Zhi 43(12):923–927
Luyten A, Hastor H, Vasileva T, Zander M, Petry KU (2014) Laser-skinning colpectomy for extended vaginal intraepithelial neoplasia and microinvasive cancer. Gynecol Oncol 135(2):217–222
Rubin SC, Young J, Mikuta JJ (1985) Squamous carcinoma of the vagina: treatment, complications, and long-term follow-up. Gynecol Oncol 20(3):346–353
Smink M, Hermans RH, Schoot DB, Luyer M, Pijnenborg JM (2013) First report of transvaginal endoscopic microsurgery in a patient with squamous cell carcinoma of the vagina. J Laparoendosc Adv Surg Tech A 23(2):154–157
Stock RG, Chen AS, Seski J (1995) A 30-year experience in the management of primary carcinoma of the vagina: analysis of prognostic factors and treatment modalities. Gynecol Oncol 56(1):45–52
Tjalma WA, Monaghan JM, de Barros Lopes A, Naik R, Nordin AJ, Weyler JJ (2001) The role of surgery in invasive squamous carcinoma of the vagina. Gynecol Oncol 81(3):360–365
Literatur zu Abschn. 9.6
Ackerman LV (1948) Verruccous carcinoma of the oral cavity. Surgery 23:670–678
Al-Kurdi M, Monaghan JM (1981) Thirty-two years experience in management of primary tumours of the vagina. Br J Obstet Gynaecol 88(11):1145–1150
Altgassen C, Hertel H, Brandstadt A, Kohler C, Durst M, Schneider A; AGO Study Group (2008) Multicenter validation study of the sentinel lymph node concept in cervical cancer. J Clin Oncol 26(18):2943–2951
Andrews SJ, Williams BT, Depriest PD et al (1994) Therapeutic implications of lymph nodal spread in lateral T1 and T2 squamous cell carcinoma of the vulva. Gynecol Oncol 55:41–46
Cheung TH, Lo KW, Yim SF, Yau SH, Yu MM, Yeung WK (2011) Debulking metastatic pelvic nodes before radiotherapy in cervical cancer patients: a long-term follow-up result. Int J Clin Oncol 16(5):546–552
Frumovitz M, Gayed IW, Jhingran A, Euscher ED, Coleman RL, Ramirez PT, Levenback CF (2008) Lymphatic mapping and sentinel lymph node detection in women with vaginal cancer. Gynecol Oncol 108(3):478–481
Frumovitz M, Etchepareborda M, Sun CC, Soliman PT, Eifel PJ, Levenback CF, Ramirez PT (2010) Primary malignant melanoma of the vagina. Obstet Gynecol 116(6):1358–1365
Gadducci A, Fabrini MG, Lanfredini N, Sergiampietri C (2015c) Squamous cell carcinoma of the vagina: natural history, treatment modalities and prognostic factors. Crit Rev Oncol Hematol 93(3):211–224
Hacker NF, Eifel PJ (2015) Vaginal cancer. In: Berek JS, Hacker NF (Hrsg) Berek & Hacker’s gynecologic oncology, 6. Aufl. Wolters Kluwer, Philadelphia
Hacker NF, Eifel PJ, van der Velden J (2012) Cancer of the vagina. Int J Gynaecol Obstet 119(Suppl 2):97–99
Hassanzade M, Attaran M, Treglia G, Yousefi Z, Sadeghi R (2013) Lymphatic mapping and sentinel node biopsy in squamous cell carcinoma of the vulva: systematic review and meta-analysis of the literature. Gynecol Oncol 130(1):237–245
Hertel H, Soergel P, Muecke J, Schneider M, Papendorf F, Laenger F, Gratz KF, Hillemanns P (2013) Is there a place for sentinel technique in treatment of vaginal cancer? Feasibility, clinical experience, and results. Int J Gynecol Cancer 23(9):1692–1698
Horn LC, Einenkel J, Hockel M, Kolbl H, Kommoss F, Lax SF, Riethdorf L, Schnurch HG, Schmidt D (2005) Recommendations for the handling and oncologic pathology report of lymph node specimens submitted for evaluation of metastatic disease in gynecologic malignancies. Pathologe 26(4):266–272
Hyde SE, Valmadre S, Hacker NF, Schilthuis MS, Grant PT, van der Velden J (2007) Squamous cell carcinoma of the vulva with bulky positive groin nodes-nodal debulking versus full groin dissection prior to radiation therapy. Int J Gynecol Cancer 17(1):154–158
Ishida H, Nagai T, Sato S, Honda M, Uotani T, Samejima K, Hanaoka T, Akahori T, Takai Y, Seki H (2015) Concomitant sentinel lymph node biopsy leading to abbreviated systematic lymphadenectomy in a patient with primary malignant melanoma of the vagina. Springerplus 4:102
Ivanov SI (2008) Modern tendencies in treatment of endometrial cancer stage III C. Akush Ginekol (Sofiia) 47(3):29–31
Jimenez-Heffernan A, Ellmann A, Sado H, Huic D, Bal C, Parameswaran R, Giammarile F, Pruzzo R, Kostadinova I, Vorster M, Almeida P, Santiago J, Gambhir S, Sergieva S, Calderon A, Young GO, Valdes-Olmos R, Zaknun J, Magboo VP, Pascual TN (2015) Results of a prospective multicenter International Atomic Energy Agency Sentinel Node Trial on the value of SPECT/CT over planar imaging in various malignancies. J Nucl Med 56(9):1338–1344
Kraus FT, Perezmesa C (1966) Verrucous carcinoma. Clinical and pathologic study of 105 cases involving oral cavity, larynx and genitalia. Cancer 19(1):26–38
Kurman RJ, Carcangiu ML, Herrington CS, Young RH (Hrsg) (2014) WHO classification of tumours of female reproductive organs. IARC Press, Lyon
Kurman RJ, Toki T, Schiffman MH (1993) Basaloid and warty carcinomas of the vulva. Distinctive types of squamous cell carcinoma frequently associated with human papillomaviruses. Am J Surg Pathol 17(2):133–145
Leitlinie Vaginalkarzinom (2018c) Vaginalkarzinom: Diagnostik, Therapie und Nachsorge. S2k-Leitlinie der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG). AWMF-Registernummer 032/042
Leitlinie Vulvakarzinom (2015) Vulvakarzinom und seine Vorstufen, Diagnostik und Therapie. S2k-Leitlinie der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG). AWMF-Registernummer 015/059
Leitlinie Zervixkarzinom (2014) Diagnostik, Therapie und Nachsorge der Patientin mit Zervixkarzinom, Langversion. S3-Leitlinie des Leitlinienprogramms Onkologie (AWMF, Deutsche Krebsgesellschaft, Deutsche Krebshilfe). AWMF-Registernummer: 032/033OL
Lens MB, Dawes M, Newton-Bishop JA, Goodacre T (2002) Management of regional lymph nodes in patients with malignant melanoma: questionnaire survey of UK current practice. Br J Plast Surg 55(5):372–375
Lim MC, Bae J, Park JY, Lim S, Kang S, Seo SS, Kim JY, Rho JW, Park SY (2008) Experiences of pretreatment laparoscopic surgical staging in patients with locally advanced cervical cancer: results of a prospective study. J Gynecol Oncol 19(2):123–128
Marcus SL (1960) Primary carcinoma of the vagina. Obstet Gynecol 15:673–689
Marnitz S, Kohler C, Roth C, Fuller J, Hinkelbein W, Schneider A (2005) Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer? Gynecol Oncol 99(3):536–544
Marnitz S, Kohler C, Roth C, Fuller J, Bischoff A, Wendt T, Schneider A, Budach V (2007) Stage-adjusted chemoradiation in cervical cancer after transperitoneal laparoscopic staging. Strahlenther Onkol 183(9):473–478
Meads C, Sutton AJ, Rosenthal AN, Malysiak S, Kowalska M, Zapalska A, Rogozinska E, Baldwin P, Ganesan R, Borowiack E, Barton P, Roberts T, Khan K, Sundar S (2014) Sentinel lymph node biopsy in vulval cancer: systematic review and meta-analysis. Br J Cancer 110(12):2837–2846
Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Reintgen DS, Coventry BJ, Glass EC, Wang HJ, Group M (2006) Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355(13):1307–1317
Mota F (2003) Microinvasive squamous carcinoma of the cervix: treatment modalities. Acta Obstet Gynecol Scand 82(6):505–509
Nakagawa S, Koga K, Kugu K, Tsutsumi O, Taketani Y (2002) The evaluation of the sentinel node successfully conducted in a case of malignant melanoma of the vagina. Gynecol Oncol 86(3):387–389
Nooij LS, Ongkiehong PJ, van Zwet EW, Bosse T, Creutzberg CL, Gaarenstroom KN, van Poelgeest MI (2015) Groin surgery and risk of recurrence in lymph node positive patients with vulvar squamous cell carcinoma. Gynecol Oncol 139(3):458–464
Peters WA 3rd, Kumar NB, Morley GW (1985) Microinvasive carcinoma of the vagina: a distinct clinical entity? Am J Obstet Gynecol 153(5):505–507
Plentl AA, Friedman EA (1971) Lymphatic system of the female genitalia. The morphologic basis of oncologic diagnosis and therapy. Major Probl Obstet Gynecol 2:1–223
Renaud MC, Plante M, Gregoire J, Roy M (2009) Primitive clear cell carcinoma of the vagina treated conservatively. J Obstet Gynaecol Can 31(1):54–56
Selman TJ, Mann C, Zamora J, Appleyard TL, Khan K (2008) Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis. CMAJ 178(7):855–862
Stehman FB, Bundy BN, Dvoretsky PM et al (1992) Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet Gynecol 79:490–497
Tax C, Rovers MM, de Graaf C, Zusterzeel PL, Bekkers RL (2015) The sentinel node procedure in early stage cervical cancer, taking the next step a diagnostic review. Gynecol Oncol 139(3):559–567
van Dam P, Sonnemans H, van Dam PJ, Verkinderen L, Dirix LY (2004) Sentinel node detection in patients with vaginal carcinoma. Gynecol Oncol 92(1):89–92
van de Lande J, Torrenga B, Raijmakers PG, Hoekstra OS, van Baal MW, Brolmann HA, Verheijen RH (2007) Sentinel lymph node detection in early stage uterine cervix carcinoma: a systematic review. Gynecol Oncol 106(3):604–613
van der Zee AG, Oonk MH, De Hullu JA, Ansink AC, Vergote I, Verheijen RH, Maggioni A, Gaarenstroom KN, Baldwin PJ, van Dorst EB, van der Velden J, Hermans RH, van der Putten H, Drouin P, Schneider A, Sluiter WJ (2008) Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 26(6):884–889
Waggoner SE, Mittendorf R, Biney N, Anderson D, Herbst AL (1994) Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma. Gynecol Oncol 55(2):238–244
Wilkinson EJ, Rico MJ, Pierson KK (1982) Microinvasive carcinoma of the vulva. Int J Gynecol Pathol 1:29–39
Wölber L, Eulenburg C, Grimm D, Trillsch F, Bohlmann I, Burandt E, Dieckmann J, Klutmann S, Schmalfeldt B, Mahner S, Prieske K (2016) The risk of contralateral non-sentinel metastasis in patients with primary vulvar cancer and unilaterally positive sentinel node. Ann Surg Oncol 23(8):2508–2514
Zaino RJ, Nucci M, Kurman RJ (2011) Diseases of the Vagina. In: Kurman RJ, Ellenson LH, Ronnett BM (Hrsg) Blaustein’s pathology of the female genital tract. Springer, Heidelberg
Literatur zu Abschn. 9.7
Aktas M, de Jong D, Nuyttens JJ, van der Zee J, Wielheesen DH, Batman E, Burger CW, Ansink AC (2007) Concomitant radiotherapy and hyperthermia for primary carcinoma of the vagina: a cohort study. Eur J Obstet Gynecol Reprod Biol 133:100–104
Ali MM, Huang DT, Goplerud DR, Howells R, Lu JD (1996) Radiation alone for carcinoma of the vagina: variation in response related to the location of the primary tumor. Cancer 77:1934–1939
Alonso I, Felix A, Torne A, Fuste V, del Pino M, Castillo P, Balasch J, Pahisa J, Rios J, Ordi J (2012) Human papillomavirus as a favorable prognostic biomarker in squamous cell carcinomas of the vagina. Gynecol Oncol 125:194–199
Amsbaugh MJ, El-Ghamry M, Metzinger D, Hunter T, Dunlap NE (2015) Successful pregnancy after uterus-sparing chemoradiation therapy for vaginal cancer. Pract Radiat Oncol 5:e263–266
Bakker RM, ter Kuile MM, Vermeer WM, Nout RA, Mens JWM, van Doorn LC, de Kroon CD, Hompus WCP, Braat C, Creutzberg CL (2014) Sexual Rehabilitation After Pelvic Radiotherapy and Vaginal Dilator Use Consensus Using the Delphi Method. Int J Gynecol Cancer 24:1499–1506
Bakker RM, Vermeer WM, Creutzberg CL, Mens JWM, Nout RA, ter Kuile MM (2015) Qualitative accounts of patients’ determinants of vaginal dilator use after pelvic radiotherapy. J Sex Med 12:764–773
Bakker RM, Mens JW, de Groot HE, Tuijnman-Raasveld CC, Braat C, Hompus WC, Poelman JG, Laman MS, Velema LA, de Kroon CD et al (2017) A nurse-led sexual rehabilitation intervention after radiotherapy for gynecological cancer. Support Care Cancer 25(3):729–737
Chang JH, Jang WI, Kim YB, Kim JH, Kim YS, Kim YS, Park W, Kim J, Yoon WS, Kim JY, Kim HJ (2016) Definitive treatment of primary vaginal cancer with radiotherapy: multi-institutional retrospective study of the Korean Radiation Oncology Group (KROG 12–09). J Gynecol Oncol 27:e17
Cho LP, Kim CK, Viswanathan AN (2015) Pilot study assessing (18)F-fluorothymidine PET/CT in cervical and vaginal cancers before and after external beam radiation. Gynecol Oncol Rep 14:34–37
Chyle V, Zagars GK, Wheeler JA, Wharton JT, Delclos L (1996) Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors. Int J Radiat Oncol Biol Phys 35:891–905
Damast S, Takiar V, McCarthy S, Higgins SA (2016) Treatment of early stage vaginal cancer with EBRT and MRI-based intracavitary brachytherapy: a retrospective case review. Gynecol Oncol Rep 17:89–92
Fine BA, Piver MS, McAuley M, Driscoll D (1996) The curative potential of radiation therapy in the treatment of primary vaginal carcinoma. Am J Clin Oncol 19:39–44
Frank SJ, Jhingran A, Levenback C, Eifel PJ (2005) Definitive radiation therapy for squamous cell carcinoma of the vagina. Int J Radiat Oncol Biol Phys 62:138–147
Frumovitz M, Gayed IW, Jhingran A, Euscher ED, Coleman RL, Ramirez PT, Levenback CF (2008) Lymphatic mapping and sentinel lymph node detection in women with vaginal cancer. Gynecol Oncol 108:478–481
Gardner CS, Sunil J, Klopp AH, Devine CE, Sagebiel T, Viswanathan C, Bhosale PR (2015) Primary vaginal cancer: role of MRI in diagnosis, staging and treatment. Br J Radiol 88:20150033
Ghia AJ, Gonzalez VJ, Tward JD, Stroup AM, Pappas L, Gaffney DK (2011) Primary vaginal cancer and chemoradiotherapy: a patterns-of-care analysis. Int J Gynecol Cancer 21:378–384
Greenwalt JC, Amdur RJ, Morris CG, Morgan LS, Castagno J, Markham MJ, Rich S, Yeung AR (2015) Outcomes of definitive radiation therapy for primary vaginal carcinoma. Am J Clin Oncol 38:583–587
Hegemann S, Schafer U, Lelle R, Willich N, Micke O (2009) Long-term results of radiotherapy in primary carcinoma of the vagina. Strahlenther Onkol 185:184–189
Hertel H, Soergel P, Muecke J, Schneider M, Papendorf F, Laenger F, Gratz KF, Hillemanns P (2013) Is there a place for sentinel technique in treatment of vaginal cancer? Feasibility, clinical experience, and results. Int J Gynecol Cancer 23:1692–1698
Hiniker SM, Roux A, Murphy JD, Harris JP, Tran PT, Kapp DS, Kidd EA (2013) Primary squamous cell carcinoma of the vagina: prognostic factors, treatment patterns, and outcomes. Gynecol Oncol 131:380–385
Jang WI, Wu HG, Ha SW, Kim HJ, Kang SB, Song YS, Park NH, Kim JW (2012) Definitive radiotherapy for treatment of primary vaginal cancer: effectiveness and prognostic factors. Int J Gynecol Cancer 22:521–527
Kirchheiner K, Nout RA, Tanderup K, Lindegaard JC, Westerveld H, Haie-Meder C, Petric P, Mahantshetty U, Dorr W, Potter R (2014) Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study. Int J Radiat Oncol Biol Phys 89:88–95
Kirkbride P, Fyles A, Rawlings GA, Manchul L, Levin W, Murphy KJ, Simms J (1995) Carcinoma of the Vagina – Experience at the Princess-Margaret-Hospital (1974–1989). Gynecol Oncol 56:435–443
Laliscia C, Fabrini MG, Delishaj D, Coraggio G, Morganti R, Tana R, Paiar F, Gadducci A (2016) Concomitant external-beam irradiation and chemotherapy followed by high-dose rate brachytherapy boost in the treatment of squamous cell carcinoma of the vagina: a single-center retrospective study. Anticancer Res 36:1885–1889
Lian J, Dundas G, Carlone M, Ghosh S, Pearcey R (2008) Twenty-year review of radiotherapy for vaginal cancer: an institutional experience. Gynecol Oncol 111:298–306
Miyamoto DT, Viswanathan AN (2013) Concurrent chemoradiation for vaginal cancer. PLoS One 8:e65048
Murakami N, Kasamatsu T, Sumi M, Yoshimura R, Takahashi K, Inaba K, Morota M, Mayahara H, Ito Y, Itami J (2013) Radiation therapy for primary vaginal carcinoma. J Radiat Res 54:931–937
Nori D, Hilaris BS, Stanimir G, Lewis JL Jr (1983) Radiation therapy of primary vaginal carcinoma. Int J Radiat Oncol Biol Phys 9:1471–1475
Oldan JD, Patel PS (2016) Positron emission tomography/computed tomography for gynecologic malignancies. Obstet Gynecol Surv 71:545–556
Orton A, Boothe D, Williams N, Buchmiller T, Huang YJ, Suneja G, Poppe M, Gaffney D (2016) Brachytherapy improves survival in primary vaginal cancer. Gynecol Oncol 141:501–506
Pingley S, Shrivastava SK, Sarin R, Agarwal JP, Laskar S, Deshpande DD, Dinshaw KA (2000) Primary carcinoma of the vagina: Tata Memorial Hospital experience. Int J Radiat Oncol Biol Phys 46:101–108
Pirtoli L, Santoni R (1980) Radiation therapy of primary vaginal carcinoma. Acta Radiol Oncol 19:353–356
RKI (2017) Krebs in Deutschland 2013/2014. Robert-Koch-Institut, Zentrum für Krebsregisterdaten, Berlin
Samant R, Lau BEC, Le T, Tam T (2007) Primary vaginal cancer treated with concurrent chemoradiation using Cis-platinum. Int J Radiat Oncol Biol Phys 69:746–750
Sinha B, Stehman F, Schilder J, Clark L, Cardenes H (2009) Indiana University experience in the management of vaginal cancer. Int J Gynecol Cancer 19:686–693
Spirtos NM, Doshi BP, Kapp DS, Teng N (1989) Radiation therapy for primary squamous cell carcinoma of the vagina: Stanford University experience. Gynecol Oncol 35:20–26
Stryker JA (2000) Radiotherapy for vaginal carcinoma: a 23-year review. Br J Radiol 73:1200–1205
Tran PT, Su Z, Lee P, Lavori P, Husain A, Teng N, Kapp DS (2007) Prognostic factors for outcomes and complications for primary squamous cell carcinoma of the vagina treated with radiation. Gynecol Oncol 105:641–649
van der Zee J, Kleynen CE, Nuyttens JJ, Ansink AC (2008) Hyperthermia to improve results in vaginal cancer. Radiother Oncol 88:286–287
Literatur zu Abschn. 9.8
Benedetti Panici P, Bellati F, Plotti F et al (2008) Neoadjuvant chemotherapy followed by radical surgery in patients affected by vaginal carcinoma. Gynecol Oncol 111(2):307–311
Di Donato V, Bellati F, Fischetti M et al (2012) Vaginal cancer. Clin Rev Oncol Hematol 81:286–295
Geisler JP, Manahan KJ, Buller RE (2006) Neoadjuvant chemotherapy in vulvar cancer: avoiding promary exenteration. Gynecol Oncol 100:53–57
Hacker NF, Eifel PJ, van der Velden J (2015) Cancer of the vagina. Int J Gynecol Obstet 131:84–87
Kim JY, Lee KA, Kim BG et al (2013) Vaginal cancer with multiple liver and pulmonary metastases that achieved long-term survival. Obstet Gynecol Sci 56(6):416–419
Long HJ 3rd, Cross WG, Wieand HS et al (1995) Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent carcinoma of the uterine cervix and vagina. Gynecol Oncol 57(2):235–239
Long HJ 3rd, Rayson S, Podratz KC et al (2002) Long-term survival of patients with advanced/recurrent carcinoma of cervix and vagina after neoadjuvant treatment with methotrexate, vinblastine, doxorubicin, and cisplatin with or without the addition of molgramostim, and review of the literature. Am J Clin Oncol 25(6):547–551
Lv L, Sun Y, Liu H et al (2010) Neoadjuvnat chemotherapy followed by radical surgery and reconstraction oft the vagina in a patient with stage II primary vaginal squamous carcinoma. J Obstet Gynaecol 36(6):1245–1248
Mabuchi Y, Yahata T, Kobayashi A et al (2015) Vaginal carcinoma in a young woman who underwent fertility-sparing treatment involving chemotherapy and conservative surgery. J. Obstet Gynaecol Res 41(6):989–992
Takemoto S, Ushijima K, Nakaso K, et al (2009) Primary adenocarcinoma of the vagina successfully treated with neoadjuvant chemotherapy consisting of paclitaxel and carboplatin. J Obstet Gynaecol Res 35 (3): 579–583
Tessarolo M, Ferraris G, Re A et al (1994) Advanced primary squamous carcinoma of the vagina treated with carboplatinum. A case report. Eur J Gynaecol Oncol 15(3):230–234
Tewari KS, Mw Sill, Long HJ 3rd et al (2014) Improved survival with bevacizumab in advanced cervical cancer. The N Eng J Med 370:734–743
Literatur zu Abschn. 9.9
Abbott-Anderson K, Kwekkeboom KL (2012) A systematic review of sexual concerns reported by gynecological cancer survivors. Gynecol Oncol 124(3):477–489
Bakker RM, ter Kuile MM, Vermeer WM, Nout RA, Mens JW, van Doorn LC, de Kroon CD, Hompus WC, Braat C, Creutzberg CL (2014) Sexual rehabilitation after pelvic radiotherapy and vaginal dilator use: consensus using the Delphi method. Int J Gynecol Cancer 24(8):1499–1506
Bakker RM, Vermeer WM, Creutzberg CL, Mens JWM, Nout RA, ter Kuile MM (2015) Qualitative accounts of patients’ determinants of vaginal dilator use after pelvic radiotherapy. J Sex Med 12:764–773
Dannecker C, Strnad V, Hegewisch-Becker S (2014) Nachsorge beim Vulva- und Vaginalkarzinom. Onkologe 20:355–357
Esplen MJ, Hunter J, Leszcz M, Warner E, Narod S, Metcalfe K, Glendon G, Butler K, Liede A, Young MA, Kieffer S, DiProspero L, Irwin E, Wong J (2004) A multicenter study of supportive-expressive group therapy for women with BRCA1/BRCA2 mutations. Cancer 101(10):2327–2340
Flynn P, Kew F, Kisely SR (2009) Interventions for psychosexual dysfunction in women treated for gynaecological malignancy. Cochrane Database Syst Rev 15(2): CD004708
Gadducci A, Fabrini MG, Lanfredini N, Sergiampietri C (2015d) Squamous cell carcinoma of the vagina – natural history, treatment modalities and prognostic factors. Crit Rev Oncol Hematol 93(3):211–224
Gorini G, Carreras G, Giordano L, Anghinoni E, Iossa A, Coppo A, Talassi F, Galavotti M, Chellini E; SPRINT Working Group (2012) The Pap smear screening as an occasion for smoking cessation and physical activity counselling: effectiveness of the SPRINT randomized controlled trial. BMC Public Health 5:712–740
Gunderson CC, Nugent EK, Yunker AC, Rocconi RP, Graybill WS, Erickson BK, Moore KN (2013) Vaginal cancer: the experience from 2 large academic centers during a 15-year period. J Low Genit Tract Dis 17(4):409–413
Hellman K, Lundell M, Silfverswärd C, Nilsson B, Hellström AC, Frankendal B (2006) Clinical and histopathologic factors related to prognosis in primary squamous cell carcinoma of the vagina. Int J Gynecol Cancer 16(3):1201–1211
Leitlinie Vulvakarzinom (2015) Vulvakarzinom und seine Vorstufen, Diagnostik und Therapie. S2k-Leitlinie der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG). AWMF Registernummer 015/059. http://www.awmf.org/leitlinien/detail/ll/015-059.html
Leitlinie Zervixkarzinom (2014c) Diagnostik, Therapie und Nachsorge der Patientin mit Zervixkarzinom, Langversion. S3-Leitlinie des Leitlinienprogramms Onkologie (AWMF, Deutsche Krebsgesellschaft, Deutsche Krebshilfe). AWMF-Registernummer: 032/033OL
Oonk MH, de Hullu JA, Hollema H, Mourits MJ, Pras E, Wymenga AN, van der Zee AG (2003) The value of routine follow-up in patients treated for carcinoma of the vulva. Cancer 98(12):2624–2629
Palacios S, Castelo-Branco C, Cancelo MJ, Vázquez F (2005) Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy. Maturitas 50(2):98–104
Salani R, Backes FJ, Fung MF, Holschneider CH, Parker LP, Bristow RE, Goff BA (2011) Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. Am J Obstet Gynecol 204(6):466–478
Santoso JT, Crigger M, English E, Wan J, Likes W (2012) Smoking cessation counseling in women with genital intraepithelial neoplasia. Gynecol Oncol 125(3):716–719
Shah CA, Goff BA, Lowe K, Peters WA 3rd, Li CI (2009) Factors affecting risk of mortality in women with vaginal cancer. Obstet Gynecol 113(5):1038–1045
Swanson SG, Drosman S, Helmond FA, Stathopoulos VM (2006) Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study. Menopause 13(6):917–925
Urbański K, Kojs Z, Reinfuss M, Fabisiak W (1996) Primary invasive vaginal carcinoma treated with radiotherapy: analysis of prognostic factors. Gynecol Oncol 60(1):16–21
Walker LM, Robinson JW (2009) Qualitative exploration of healthcare relationships following delayed diagnosis of ovarian cancer and subsequent participation in supportive-expressive group therapy. Oncol Nurs Forum 36(6):E310–316
Literatur zu Abschn. 9.10
Baiocchi G, Guimaraes GC, Rosa Oliveira RA, Kumagai LY, Faloppa CC, Aguiar S, Begnami MD, Soares FA, Lopes A (2012) Prognostic factors in pelvic exenteration for gynecological malignancies. Eur J Surg Oncol 38:948–954
Benn T, Brooks RA, Zhang Q, Powell MA, Thaker PH, Mutch DG, Zighelboim I (2011) Pelvic exenteration in gynecologic oncology: a single institution study over 20 years. Gynecol Oncol 122:14–18
Chang JH, Jang WI, Kim YB, Kim JH, Kim YS, Kim YS, Park W, Kim J, Yoon WS, Kim JY, Kim HJ (2016) Definitive treatment of primary vaginal cancer with radiotherapy: multi-institutional retrospective study of the Korean Radiation Oncology Group (KROG 12–09). J Gynecol Oncol 27(2):e17. https://doi.org/10.3802/jgo.2016.27.e17
Gadducci A, Fabrini MG, Lanfredini N, Sergiampietri C (2015) Squamous cell carcinoma of the vagina: natural history, treatment modalities and prognostic factors. Crit Rev Oncol Hematol 93: 211–224. Review
Gardner CS, Sunil J, Klopp AH, Devine CE, Sagebiel T, Viswanathan C, Bhosale PR (2015c) Primary vaginal cancer: role of MRI in diagnosis, staging and treatment. Br J Radiol 88:20150033. https://doi.org/10.1259/bjr.20150033
Gunderson CC, Nugent EK, Yunker AC, Rocconi RP, Graybill WS, Erickson BK, Moore KN (2013c) Vaginal cancer: the experience from 2 large academic centers during a 15-year period. J Low Genit Tract Dis 17:409–413
Höckel M, Horn LC, Einenkel J (2012) (Laterally) extended endopelvic resection: surgical treatment of locally advanced and recurrent cancer of the uterine cervixand vagina based on ontogenetic anatomy. Gynecol Oncol 127:297–302
Lutz S, Berk L, Chang E, Chow E, Hahn C, Hoskin P, Howell D, Konski A, Kachnic L, Lo S, Sahgal A, Silverman L, von Gunten C, Mendel E, Vassil A, Bruner DW, Hartsell W; American Society for Radiation Oncology (ASTRO) (2011) Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 79:965–976
Singh DP, Bylund KC, Matloubieh A, Mazloom A, Gray A, Sidhu R, Barrette L, Chen Y (2015) Is there a subset of patients with recurrent cancer in the vagina who are not candidates for interstitial brachytherapy that can be treated with multichannel vaginal brachytherapy using graphic optimization? J Contemp Brachytherapy 7: 135–41
Smith SC, Koh WJ (2001) Palliative radiation therapy for gynaecological malignancies. Best Pract Res Clin Obstet Gynaecol 15: 265–278. Review
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Ackermann, S. et al. (2018). Invasives Karzinom der Vagina. In: Schnürch, HG., Hampl, M., Wölber, L. (eds) Tumorerkrankungen der Vulva und Vagina. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-56636-7_9
Download citation
DOI: https://doi.org/10.1007/978-3-662-56636-7_9
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-56635-0
Online ISBN: 978-3-662-56636-7
eBook Packages: Medicine (German Language)